By Andrew M. Seaman NEW YORK (Reuters Health) - Men who get an older and less costly form of radiation after their cancerous prostates are removed fare just as well as men who get a new and expensive type of radiation, according to a new study. &q... More »
JOHANNESBURG (Reuters) - More than 20 South African boys have died over the past week during coming of age rituals, police said on Thursday, and they blamed botched circumcisions as the likely cause of death. Northern Mpumalanga province's pol... More »
A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. More »
TRENTON, N.J. (AP) — Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill. More »
TRENTON, N.J. (AP) — Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill. More »
By Andrew M. Seaman NEW YORK (Reuters Health) - Despite dietary supplements being popular among prostate cancer patients, a new review of past research says they are not effective treatments for the disease. Pulling together data from eight random... More »
By Toni Clarke (Reuters) - An advisory panel to the U.S. Food and Drug Administration was sharply divided on Thursday over whether a drug made by Endo Health Solutions Inc can safely be prescribed for men with low testosterone. A panel of outside ... More »
(Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's twice-rejected testosterone injection Aveed was "concerning" and showed that the therapy was associated with severe and i... More »
By Genevra Pittman NEW YORK (Reuters Health) - Most older men with prostate cancer found by prostate-specific antigen (PSA) tests and biopsies opted for treatment in a new study - even if signs pointed to their disease being slow-growing and not i... More »
By Genevra Pittman NEW YORK (Reuters Health) - The American College of Physicians (ACP) became the latest group to ask doctors to be clear about the limited benefits and "substantial harms" of prostate cancer screening before offering th... More »